| Literature DB >> 30611224 |
Wadena D Burnett1, Saija A Kontulainen1, Christine E McLennan2, Diane Hazel2, Carl Talmo2, David R Wilson3, David J Hunter4, James D Johnston5.
Abstract
BACKGROUND: Subchondral bone cysts are a widely observed, but poorly understood, feature in patients with knee osteoarthritis (OA). Clinical quantitative computed tomography (QCT) has the potential to characterize cysts in vivo but it is unclear which specific cyst parameters (e.g., number, size) are associated with clinical signs of OA, such as disease severity or pain. The objective of this study was to use QCT-based image-processing techniques to characterize subchondral tibial cysts in patients with knee OA and to explore relationships between proximal tibial subchondral cyst parameters and subchondral bone density as well as clinical characteristics of OA (alignment, joint space narrowing (JSN), OA severity, pain) in patients with knee OA.Entities:
Keywords: Bone mineral density; Computed tomography; Osteoarthritis; Tibia
Mesh:
Year: 2019 PMID: 30611224 PMCID: PMC6320646 DOI: 10.1186/s12891-018-2388-9
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Process for identifying, isolating, and measuring cysts included isolating the subchondral region of 7.5 mm from the subchondral surface (a), cyst identification on CT images (b), and segmenting individual cysts using semi-automatic region growing for larger cysts manual segmentation for smaller cysts (c). Segmented image volumes were then used to measure cyst parameters, and regional BMD excluding cysts which included total, lateral, and medial regions (d)
Descriptive statistics for characteristics of study participants
| Characteristic | Parameters |
|---|---|
| Age, years (mean ± SD) | 64.1 ± 10.1 |
| Sex (M:F) | 17:25 |
| BMI, kg/m2 (mean ± SD) | 28.7 ± 3.7 |
| Side (L:R) | 18:24 |
| OA Severity (KL) (Score of 0/1/2/3/4) | 0/0/2/21/19 |
| Medial OA severity (KL) (Score of 0/1/2/3/4) | 3/7/7/14/11 |
| Lateral OA severity (KL) (Score of 0/1/2/3/4) | 13/18/3/6/2 |
| WOMAC Score (score range: 0 to 20) | 9.8 ± 2.9 |
| Medial Joint Space Narrowing (JSN) (Score of 0/1/2/3) | 10/6/10/14a |
| Lateral Joint Space Narrowing (JSN) (Score of 0/1/2/3) | 30/5/1/4a |
| Non-weight-bearing alignment | 28 varus, 6 neutral, 8 valgus |
| Total BMD, mg/cm3 K2HPO4 (mean ± SD) | 279 ± 51 |
| Medial BMD, mg/cm3 K2HPO4(mean ± SD) | 311 ± 88 |
| Lateral BMD, mg/cm3 K2HPO4(mean ± SD) | 240 ± 58 |
aData missing for 2 participants
Cyst parameters for study sample (n = 42), mean ± SD (median, range). Cysts were present in 88% of participants (37/42). Of the 37 participants with subchondral cysts, 33 had cysts medially and 18 had cysts laterally. For these reasons, in some cases the median value is 0. Cyst parameters specific to the 37 participants with subchondral cysts can be found in Additional file 3: Table S3
| Total | Medial | Lateral | |
|---|---|---|---|
| Cyst Number (Cyst.N) (#) | 7.0 ± 6.7 (5.5, 0–30) | 3.9 ± 5.7 (2.0, 0–29) | 1.9 ± 3.0 (0.0, 0–11) |
| Cyst #/vol (Cyst.N/TV) (#/cm3) | 0.3 ± 0.3 (0.3, 0–1.3) | 0.4 ± 0.6 (0.2, 0–2.6) | 0.2 ± 0.3 (0.0, 0–1.3) |
| Cyst vol/vol (Cyst.V/TV) (%) | 1.3 ± 2.7 (0.0, 0–14.8) | 1.9 ± 2.5 (0.0, 0–24.5) | 0.2 ± 0.5 (0.0, 0–5.3) |
| Total cyst volume (Tot.Cyst.V) (mm3) | 133.5 ± 245.8 (44.3, 0–1253) | 98.6 ± 232.3 (15.4, 0–1156) | 16.5 ± 44.1 (0.0, 0–241.0) |
| Maximum cyst volume (Max.Cyst.V)(mm3) | 70.4 ± 140.6 (21.9, 0–685.8) | 58.0 ± 141.5 (7.7, 0–685.8) | 9.5 ± 32.5 (0.0, 0–201.9) |
| Average cyst volume (Avg.Cyst.V) (mm3) | 16.7 ± 25.8 (6.6, 0–139.2) | 21.9 ± 49.9 (4.9, 0–289.1) | 2.6 ± 4.5 (0.0, 0–21.9) |
Correlation coefficients between cyst parameters and patient and clinical OA characteristics over the total proximal tibia. Spearman’s correlation coefficient was used for all variables. For alignment, negative relationships represent associations with varus alignment while positive relationships represent associations with valgus alignment. Significant associations are marked
| Cyst.N | Cyst.N/TV | Cyst.V/TV | Tot.Cyst.V | Max.Cyst.V | Avg.Cyst.V | |
|---|---|---|---|---|---|---|
| Age | 0.17 | 0.17 | 0.11 | 0.08 | 0.07 | 0.01 |
| Sex | 0.25 | 0.37 | 0.18 | 0.11 | 0.04 | − 0.03 |
| BMI | − 0.20 | − 0.22 | − 0.08 | − 0.06 | − 0.02 | 0.05 |
| Alignment | 0.33* | 0.38* | 0.19 | 0.16 | 0.09 | 0.02 |
| KL | 0.30 | −0.07 | −0.08 | 0.37 | 0.32 | 0.31 |
| Total WOMAC Pain | 0.25 | 0.29 | 0.16 | 0.15 | 0.07 | 0.05 |
| Nocturnal Pain | 0.26 | 0.25 | 0.07 | 0.09 | −0.01 | −0.09 |
| Total BMD | 0.07 | 0.03 | 0.02 | 0.04 | 0.03 | 0.04 |
*p < 0.05
**p < 0.01
Correlation coefficients between cyst parameters and patient and clinical OA characteristics at the medial region. Spearman’s correlation coefficient was used for all variables. For alignment, negative relationships represent associations with varus alignment while positive relationships represent associations with valgus alignment. Significant associations are marked
| Medial Cyst.N | Medial Cyst.N/TV | Medial Cyst.V/TV | Medial Tot.Cyst.V | Medial Max.Cyst.V | Medial Avg.Cyst.V | |
|---|---|---|---|---|---|---|
| Age | −0.03 | −0.01 | − 0.12 | −0.13 | − 0.11 | −0.11 |
| Sex | −0.03 | −0.09 | 0.08 | 0.09 | 0.10 | 0.12 |
| BMI | −0.07 | −0.11 | − 0.12 | −0.11 | − 0.10 | −0.05 |
| Alignment | −0.10 | −0.09 | − 0.14 | −0.14 | − 0.14 | 0.00 |
| Medial JSN | 0.08 | 0.06 | 0.13 | 0.13 | 0.12 | 0.02 |
| Medial KL | 0.23 | 0.23 | 0.27 | 0.26 | 0.24 | 0.21 |
| Total WOMAC Pain | 0.14 | 0.13 | 0.16 | 0.17 | 0.18 | 0.21 |
| Nocturnal Pain | −0.09 | −0.12 | −0.11 | −0.08 | −0.08 | 0.00 |
| Medial BMD | 0.42* | 0.41* | 0.38* | 0.39* | 0.35* | 0.33* |
*p < 0.05
**p < 0.01
Correlation coefficients between cyst parameters and patient and clinical OA characteristics at the lateral region. Spearman’s correlation coefficient was used for all variables. For alignment, negative relationships represent associations with varus alignment while positive relationships represent associations with valgus alignment. Significant associations are marked
| Lateral Cyst.N | Lateral Cyst.N/TV | Lateral Cyst.V/TV | Lateral Tot.Cyst.V | Lateral Max.Cyst.V | Lateral Avg.Cyst.V | |
|---|---|---|---|---|---|---|
| Age | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.22 |
| Sex | 0.62** | 0.62** | 0.62** | 0.62** | 0.62** | 0.64** |
| BMI | − 0.35* | − 0.35* | − 0.35* | − 0.36* | − 0.36* | − 0.34* |
| Alignment | 0.60** | 0.60** | 0.61** | 0.61** | 0.62** | 0.62** |
| Lateral JSN | 0.66** | 0.66** | 0.68** | 0.67** | 0.68** | 0.68** |
| Lateral KL | 0.54** | 0.54** | 0.54** | 0.54** | 0.53** | 0.51** |
| Total WOMAC Pain | 0.15 | 0.16 | 0.14 | 0.13 | 0.11 | 0.14 |
| Nocturnal Pain | 0.24 | 0.25 | 0.23 | 0.23 | 0.22 | 0.20 |
| Lateral BMD | 0.48** | 0.47** | 0.46** | 0.46** | 0.45** | 0.43** |
*p < 0.05
**p < 0.01